182 related articles for article (PubMed ID: 9784363)
1. Infectious human papillomavirus type 18 pseudovirions.
Stauffer Y; Raj K; Masternak K; Beard P
J Mol Biol; 1998 Oct; 283(3):529-36. PubMed ID: 9784363
[TBL] [Abstract][Full Text] [Related]
2. DNA binding of L1 is required for human papillomavirus morphogenesis in vivo.
Schäfer F; Florin L; Sapp M
Virology; 2002 Mar; 295(1):172-81. PubMed ID: 12033775
[TBL] [Abstract][Full Text] [Related]
3. DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1.
Zhao KN; Sun XY; Frazer IH; Zhou J
Virology; 1998 Apr; 243(2):482-91. PubMed ID: 9568045
[TBL] [Abstract][Full Text] [Related]
4. BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions.
Zhao KN; Hengst K; Liu WJ; Liu YH; Liu XS; McMillan NA; Frazer IH
Virology; 2000 Jul; 272(2):382-93. PubMed ID: 10873782
[TBL] [Abstract][Full Text] [Related]
5. Generation of HPV pseudovirions using transfection and their use in neutralization assays.
Buck CB; Pastrana DV; Lowy DR; Schiller JT
Methods Mol Med; 2005; 119():445-62. PubMed ID: 16350417
[TBL] [Abstract][Full Text] [Related]
6. Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions.
Kondo K; Ishii Y; Mori S; Shimabukuro S; Yoshikawa H; Kanda T
Virology; 2009 Nov; 394(2):259-65. PubMed ID: 19766281
[TBL] [Abstract][Full Text] [Related]
7. Generation and applications of HPV pseudovirions using vaccinia virus.
Sapp M; Selinka HC
Methods Mol Med; 2005; 119():463-82. PubMed ID: 16350418
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.
El Mehdaoui S; Touzé A; Laurent S; Sizaret PY; Rasschaert D; Coursaget P
J Virol; 2000 Nov; 74(22):10332-40. PubMed ID: 11044077
[TBL] [Abstract][Full Text] [Related]
9. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.
Mossadegh N; Gissmann L; Müller M; Zentgraf H; Alonso A; Tomakidi P
Virology; 2004 Aug; 326(1):57-66. PubMed ID: 15262495
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
[TBL] [Abstract][Full Text] [Related]
11. Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein.
Sun XY; Frazer I; Müller M; Gissmann L; Zhou J
Virology; 1995 Nov; 213(2):321-7. PubMed ID: 7491757
[TBL] [Abstract][Full Text] [Related]
12. [Virological and carcinogenic aspects of HPV].
Prétet JL; Charlot JF; Mougin C
Bull Acad Natl Med; 2007 Mar; 191(3):611-23; discussion 623. PubMed ID: 18072657
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein.
Kieback E; Müller M
Virology; 2006 Feb; 345(1):199-208. PubMed ID: 16257028
[TBL] [Abstract][Full Text] [Related]
14. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
Roden RB; Greenstone HL; Kirnbauer R; Booy FP; Jessie J; Lowy DR; Schiller JT
J Virol; 1996 Sep; 70(9):5875-83. PubMed ID: 8709207
[TBL] [Abstract][Full Text] [Related]
15. Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes.
Kondo K; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
J Med Virol; 2008 May; 80(5):841-6. PubMed ID: 18360909
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
17. Maturation of papillomavirus capsids.
Buck CB; Thompson CD; Pang YY; Lowy DR; Schiller JT
J Virol; 2005 Mar; 79(5):2839-46. PubMed ID: 15709003
[TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70.
Florin L; Becker KA; Sapp C; Lambert C; Sirma H; Müller M; Streeck RE; Sapp M
J Virol; 2004 Jun; 78(11):5546-53. PubMed ID: 15140951
[TBL] [Abstract][Full Text] [Related]
19. Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells.
Volpers C; Schirmacher P; Streeck RE; Sapp M
Virology; 1994 May; 200(2):504-12. PubMed ID: 8178438
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human papillomavirus type 1 replication by the viral E2 protein.
Van Horn G; Sheikh S; Khan SA
Virology; 2001 Aug; 287(1):214-24. PubMed ID: 11504556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
